marijuana stocks news

Manzo Pharmaceuticals, Inc. (MNZO)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 0   1   –   –  
Cost of Revenue
Gross Profit 0   1   –   –  
Operating Expenses
Research Development
Selling General and Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss 3,009   (2,995) (130) (130)
Income from Continuing Operations
Total Other Income/Expenses Net (199)
Earnings Before Interest And Taxes 2,811 (2,999) (130) (130)
Interest Expense (5,788) 6,328
Income Before Tax 8,598 (9,328) (130) (130)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops 8,598 (9,328) (130) (130)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 8,598   (9,328) (130) (130)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares 8,598   (9,328) (130) (130)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published.

You May Also Like

Organigram Holdings Inc. (OGRMF) ranked as 4th best performing stock on the OTCQX® Best Market for 2018

Organigram ranked as 4th best performing stock on the OTCQX® Best Market…

$EAPH Letter to Shareholders

Easton Pharmaceuticals Letter to Shareholders  Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Dear…

American Premium Water Corporation (HIPH) Announces Expanded Distribution into Wal-Mart

American Premium Water Corp. (OTC: HIPH) Announces Expanded Distribution into Wal-Mart American…